Miroslav Mares
Overview
Explore the profile of Miroslav Mares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chytilek R, Mares M, Drmola J, Hrbkova L, Mlejnkova P, Spackova Z, et al.
Qual Quant
. 2022 Feb;
56(6):4825-4840.
PMID: 35221383
Supplementary Information: The online version contains supplementary material available at 10.1007/s11135-022-01354-4.
2.
Bar-Or A, Wiendl H, Montalban X, Alvarez E, Davydovskaya M, Delgado S, et al.
Mult Scler
. 2021 Oct;
28(6):910-924.
PMID: 34605319
Background: Ofatumumab, the first fully human anti-CD20 monoclonal antibody, is approved in several countries for relapsing multiple sclerosis (RMS). Objective: To demonstrate the bioequivalence of ofatumumab administered by an autoinjector...
3.
Reich D, Arnold D, Vermersch P, Bar-Or A, Fox R, Matta A, et al.
Lancet Neurol
. 2021 Aug;
20(9):729-738.
PMID: 34418400
Background: Tolebrutinib is an oral, CNS-penetrant, irreversible inhibitor of Bruton's tyrosine kinase, an enzyme expressed in B lymphocytes and myeloid cells including microglia, which are major drivers of inflammation in...
4.
Chroustova I, Mares M, Ungermann L, Ehler E
Acta Medica (Hradec Kralove)
. 2019 Oct;
62(3):123-126.
PMID: 31663506
Antibodies against myelin oligodendrocyte glycoprotein cause inflammatory lesions of central myelin - in optic nerves, of the brainstem, and spinal cord. There are characteristic changes of CNS white matter, protein-cytological...
5.
Ehler E, Novotna A, Mares M, Musova Z, Mrklovsky M
Clin Neurol Neurosurg
. 2012 Apr;
114(10):1358-60.
PMID: 22502787
No abstract available.
6.
Kadanka Z, Mares M, Bednanik J, Smrcka V, Krbec M, Stejskal L, et al.
Spine (Phila Pa 1976)
. 2002 Oct;
27(20):2205-10; discussion 2210-1.
PMID: 12394893
Study Design: A 3-year prospective randomized study was conducted. Objective: To compare conservative and operative treatments of mild and moderate, nonprogressive, and slowly progressive forms of spondylotic cervical myelopathy. Summary...